Fernanda Piotto Frallonardo

Fernanda Piotto Frallonardo

Auto-generated profile, based on publicly available information

Fernanda Piotto Frallonardo

Municipal University of Sao Caetano do Sul (USCS), Sao Caetano do Sul, SP,Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
JCJoão Mauricio Castaldelli-Maia
João Mauricio Castaldelli-Maia
CCCarlos Felipe Cavalcanti Carvalho
Carlos Felipe Cavalcanti Carvalho
FAFábio Armentano
Fábio Armentano
FFFernanda Piotto Frallonardo
Fernanda Piotto Frallonardo
TATania Correa de Toledo Ferraz Alves
Tania Correa de Toledo Ferraz Alves
SNSérgio Nicastri
Sérgio Nicastri
Key words: Tobacco; treatment; psychiatric patients; alcohol; group therapy; CBT

29 July 2019 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
CCCarolina Hanna Chaim
Carolina Hanna Chaim
ESErica Rosanna Siu
Erica Rosanna Siu
CCCarlos Felipe Cavalcanti Carvalho
Carlos Felipe Cavalcanti Carvalho
FFFernanda Piotto Frallonardo
Fernanda Piotto Frallonardo
FIFlavia Ismael
Flavia Ismael
JCJoão Mauricio Castaldelli-Maia
João Mauricio Castaldelli-Maia
There are still few studies on predictors of smoking cessation in Brazilian samples. Experimentation with tobacco during adolescence (ETA) may be one of the important predictors. This study aimed, within the context of a treatment-seeking group of subjects, to test the hypothesis that ETA negatively affects the outcome of smoking cessation during adulthood. Retrospective (historic) cohort study conducted at a psychosocial care center in São Paulo, Brazil, between 2007 and 2010. Data on sociodemographics, smoking and medical profiles were obtained through self-report questionnaires that were completed at the baseline and at any follow-up appointment. Logistic regression models were constructed to describe factors associated with the outcome of smoking cessation, measured according to the self-reported four-week success rate among 367 outpatient smokers. ETA was found to be associated with not quitting smoking through the treatment (odds ratio = 0.57; 95% confidence interval = 0.33-0.96; P < 0.05), even after adjustment for dependence level, sociodemographics, nicotine patch use and number of years of smoking. Early exposure to nicotine may lead to higher risk of continuing smoking after treatment, in adulthood.

1 November 2021 in Current Drug Research Reviews
Verified
Journal Article
Closed access
PDF file
FFFernanda Piotto Frallonardo
Fernanda Piotto Frallonardo
DLDanielle Ruiz Lima
Danielle Ruiz Lima
CCCarlos Felipe Cavalcanti Carvalho
Carlos Felipe Cavalcanti Carvalho
ALAline Rodrigues Loreto
Aline Rodrigues Loreto
BGBruna Beatriz Sales Guimarães-Pereira
Bruna Beatriz Sales Guimarães-Pereira
JCJoão Mauricio Castaldelli-Maia
João Mauricio Castaldelli-Maia
Background: Despite the well-documented relationship between weight gain and poorer cessation outcomes among smokers, the role of the former (baseline) weight in smoking cessation is insufficiently investigated. We hypothesized that patients with higher baseline body mass index( BMI) have a worse prognosis in tobacco cessation. Objectives: This retrospective clinical cohort study aimed to investigate the role of the baseline BMI on abstinence over 12 months after participation in smoking cessation treatment conducted in a middle-income country (n = 664). Methods: Data from a 6-week smoking cessation protocol performed in a Psychosocial Care Unit (CAPS) were used. The protocol included four medical consultations and six Cognitive-Behavioral Therapy (CBT) group sessions. Initially, 1,213 participants were evaluated for the study, but only the participants whose telephone contact was successful were included in the outcome analyses. The attrition rate was 45.3%. Continuous and categorical (normal, overweight, and obesity) BMI values were computed. Survival regression models were used to test the associations between BMI and the 12-month abstinence outcome. Self-report 4-week abstinence at the end of treatment was also investigated using logistic regression models. Results: Baseline BMI had no significant effect on both short (4-week-point abstinence) and long (12-month prolonged abstinence) treatment outcomes. Conclusion: The possible influence of the baseline BMI on smoking cessation outcomes, especially considering prolonged abstinence, was not corroborated by our results. Regardless of our results, the detrimental health outcomes due to the combination of obesity/overweight and smoking justify that these subgroups of individuals be continuously targeted for adequate smoking prevention and treatment.